Trademark: 90775545
Word
QXDX
Status
Registered
Status Code
700
Status Date
Tuesday, August 15, 2023
Serial Number
90775545
Registration Number
7139941
Registration Date
Tuesday, August 15, 2023
Mark Type
4000
Filing Date
Tuesday, June 15, 2021
Published for Opposition
Tuesday, October 4, 2022

Trademark Owner History
Bio-Rad Laboratories, Inc. - Original Registrant

Classifications
9 Apparatus, namely, medical laboratory research instruments and scientific laboratory research instruments for preparation, handling, amplification, and analysis of samples containing nucleic acids; accessories in the nature of laboratory apparatus, namely, sample preparation containers and kits consisting primarily of sample preparation containers and reagents, and instruction manuals sold as a unit therewith, used to prepare laboratory samples for use in scientific and medical research, all in connection with the preparation, handling, amplification, and analysis of samples containing nucleic acids; scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, namely, DNA and RNA testing apparatus; scientific laboratory equipment and apparatus, namely, digital polymerase chain reaction (dPCR) apparatus, electrophoresis apparatus, gel electrophoresis apparatus, and thermal cyclers, for use in amplifying, labeling, and analyzing nucleic acids, and parts and consumable parts therefor, namely, tubes, plates, cartridges, holders, and containers for liquids and gels; Laboratory apparatus and instruments, namely, digital Polymerase Chain Reaction (dPCR) instruments for amplifying DNA using digital Polymerase Chain Reaction (dPCR) for use in scientific research; Scientific apparatus and instruments, namely, droplet generators for sample preparation of nucleic acids and droplet reader for amplifying and analyzing samples containing nucleic acids; Downloadable and recorded software for use in for operation and maintenance of scientific apparatus, instruments and equipment, namely, operating quantitative Polymerase Chain Reaction (PCR) instruments; Polymerase Chain Reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using Polymerase Chain Reaction (PCR); downloadable computer software for use in amplifying, labeling, and analyzing nucleic acids; computer hardware and downloadable and integrated software for use in gene analysis); Downloadable and recorded computer software and hardware for processing diagnostic medical testing or laboratory data; Downloadable and recorded computer software and hardware for data analysis for use in laboratories; Downloadable and recorded computer software for operation and maintenance of scientific apparatus, instruments and equipment; Clinical medical laboratory apparatus and analytical instruments, namely, digital Polymerase Chain Reaction (dPCR) instruments for use in-vitro and in-vivo diagnostics
5 Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes, namely, reagents, enzymes, oligonucleotides, and buffer solutions for amplifying, labeling, and analyzing biopolymers and nucleic acids for diagnostic medical use and clinical use; Chemical reagents for medical or veterinary purposes; Chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; Medical diagnostic reagent kits comprised of clinical medical reagents and assays for clinical and medical use; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for diagnostic medical use and clinical use; Chemical test kits for cell assays for medical and veterinary use; Cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR)
1 Chemical reagents for scientific and medical research purposes; diagnostic reagents for clinical or medical laboratory use; Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR) reagents for scientific and medical research purposes; reagents for amplification and detection of nucleic acids for scientific and medical research purposes; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for scientific and research use; Reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research use; Kits comprising chemicals, reagents, enzymes, and buffer solutions for amplifying and labeling nucleic acids for scientific or research use; Kits consisting primarily of reagents and magnetic, polymeric, or gel beads for scientific research use purposes
10 Apparatus, namely, DNA and RNA testing apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions; Medical diagnostic apparatus and instruments, namely, Polymerase Chain Reaction (PCR) instrument to perform amplification and analyzation of nucleic acids; Medical devices and instruments, namely, a digital Polymerase Chain Reaction (dPCR) platform for use in measuring and quantifying copy number of DNA for medical diagnostic purposes; Medical devices and instruments, namely, a digital Polymerase Chain Reaction (dPCR) platform for use in measuring and quantifying copy number of DNA for medical diagnostic purposes; Diagnostic kits consisting primarily of electronic medical instruments for medical diagnosis and analysis of body fluids, tissues, biomolecules, DNA, antibodies, proteins, molecular material or cellular material
QXD X

Trademark Events
Aug 15, 2023
Notice Of Registration Confirmation Emailed
Aug 15, 2023
Registered-Principal Register
Jul 14, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 13, 2023
Allowed Principal Register - Sou Accepted
Jun 20, 2023
Statement Of Use Processing Complete
May 26, 2023
Use Amendment Filed
Jun 20, 2023
Case Assigned To Intent To Use Paralegal
May 26, 2023
Teas Statement Of Use Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 26, 2022
Approved For Pub - Principal Register
Jul 29, 2022
Teas/Email Correspondence Entered
Jul 29, 2022
Correspondence Received In Law Office
Jul 29, 2022
Teas Request For Reconsideration Received
Apr 28, 2022
Notification Of Final Refusal Emailed
Apr 28, 2022
Final Refusal E-Mailed
Apr 28, 2022
Final Refusal Written
Apr 14, 2022
Teas/Email Correspondence Entered
Apr 13, 2022
Correspondence Received In Law Office
Apr 13, 2022
Teas Response To Office Action Received
Nov 4, 2021
Notification Of Non-Final Action E-Mailed
Nov 4, 2021
Non-Final Action E-Mailed
Nov 4, 2021
Non-Final Action Written
Sep 20, 2021
Notification Of Non-Final Action E-Mailed
Sep 20, 2021
Non-Final Action E-Mailed
Sep 20, 2021
Non-Final Action Written
Sep 20, 2021
Assigned To Examiner
Sep 2, 2021
New Application Office Supplied Data Entered
Jun 18, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24